Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Optimization & Repurposing, Preclinical testing, Others); By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 20

Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Optimization & Repurposing, Preclinical testing, Others); By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 2024 - 2032



The global artificial intelligence in drug discovery market size is expected to reach USD 16.21 billion by 2032 according to a new study by Polaris Market Research. The report “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Optimization & Repurposing, Preclinical testing, Others); By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Artificial Intelligence (AI) uses complex algorithms and machine learning to acquire significant information from huge datasets. For instance, AI uses RNA sequencing data to recognize genes whose expression correlates with a given cellular condition. It employs the most recent advancements in biology to create cutting-edge medicine discovery algorithms. The increase in computer processing power, the development of advanced algorithms, and the availability of large datasets are the main drivers that led to the developments in machine learning.

Based on application, the global artificial intelligence (AI) in the drug discovery market is clustered into drug optimization & repurposing, preclinical testing, and others. The optimization & repurposing segment accounted for the largest revenue share in the industry as it is economical and demands only Electronic Medical Records (EMR) for medicine repurposing.

Based on therapeutic areas, the global market is classified into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. The oncology segment accounted for the largest revenue share in 2020 as it deals with the diagnosis and prevention of cancer.

There are some pharmaceutical companies that are focusing on integrating artificial intelligence with medicine discovery and development. For instance, Pfizer associated with IBM Watson Health, an AI platform, to augment their search for immuno-oncology treatments. Sanofi partnered with Exscientia to discover metabolic-disease therapies.

Major participants such as GNS Healthcare, DeepMind, BIOAGE, Atomwise, Euretos, Benevolent AI, OWKIN, Inc., Berg Health, BioSymetrics, Insitro, Cloud Pharmaceuticals, Cyclica, Deep Genomics, Envisagenics, Exscientia, IBM Corporation, Insilico Medicine, NuMedii, Numerate, NVIDIA Corporation, Aria Pharmaceuticals, Inc., Model Medicines, Verge Genomics, XtalPi Inc. are some of the key players operating in the global market. The companies in the industry are engaged in collaborations and expansions with several market platform providers to develop medical treatment.

Polaris Market Research has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, offering, technology, and region:

Artificial Intelligence in Drug Discovery, Application Outlook (Revenue - USD Million, 2017 - 2029)

- Drug Optimization & Repurposing

- Preclinical Testing

- Others

Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue - USD Million, 2017 - 2029)

- Oncology

- Neurodegenerative Diseases

- Cardiovascular Disease

- Metabolic Diseases

- Infectious Disease

- Others

Artificial Intelligence in Drug Discovery, Offering Outlook (Revenue - USD Million, 2017 - 2029)

- Software

- Services

Artificial Intelligence in Drug Discovery, Technology Outlook (Revenue - USD Million, 2017 - 2029)

- Machine Learning

Deep Learning

Supervised Learning

Reinforcement Learning

Unsupervised Learning

Other Machine Learning Technologies

- Other Technologies

Artificial Intelligence in Drug Discovery, Regional Outlook (Revenue - USD Million, 2017 - 2029)

- North America

U.S.

Canada

- Europe

France

Germany

UK

- Asia Pacific

China

Australia

Japan

- Latin America

- Middle East & Africa


1. Introduction
1. Report Description
1. Objectives of the Study
2. Market Scope
3. Assumptions
2. Stakeholders
2. Executive Summary
1. Market Highlights
3. Research Methodology
1. Overview
1. Data Mining
2. Data Sources
1. Primary Sources
2. Secondary Sources
4. Global Artificial Intelligence in Drug Discovery Market Insights
1. Artificial Intelligence in Drug Discovery – Industry Snapshot
2. Artificial Intelligence in Drug Discovery Market Dynamics
1. Drivers and Opportunities
1. Technological advancements in AI
2. Rising industrial partnerships and collaborations
2. Restraints and Challenges
1. Inadequate accessibility of data sets
3. Porter’s Five Forces Analysis
1. Bargaining Power of Suppliers (Moderate)
2. Threats of New Entrants: (Low)
3. Bargaining Power of Buyers (Moderate)
4. Threat of Substitute (Moderate)
5. Rivalry among existing firms (High)
4. PESTLE Analysis
5. Artificial Intelligence in Drug Discovery Industry Trends
6. COVID-19 Impact Analysis
5. Global Artificial Intelligence in Drug Discovery Market, by Application
1. Key Findings
2. Introduction
1. Global Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
3. Drug Optimization & Repurposing
1. Global Artificial Intelligence in Drug Discovery Market, by Drug Optimization & Repurposing, by Region, 2017 - 2029 (USD Million)
4. Preclinical Testing
1. Global Artificial Intelligence in Drug Discovery Market, by Preclinical Testing, by Region, 2017 - 2029 (USD Million)
5. Others
1. Global Artificial Intelligence in Drug Discovery Market, by Other Applications, by Region, 2017 - 2029 (USD Million)
6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area
1. Key Findings
2. Introduction
1. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
3. Oncology
1. Global Artificial Intelligence in Drug Discovery Market, by Oncology, by Region, 2017 - 2029 (USD Million)
4. Neurodegenerative Diseases
1. Global Artificial Intelligence in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2017 - 2029 (USD Million)
5. Cardiovascular Disease
1. Global Artificial Intelligence in Drug Discovery Market, by Cardiovascular Disease, by Region, 2017 - 2029 (USD Million)
6. Metabolic Diseases
1. Global Artificial Intelligence in Drug Discovery Market, by Metabolic Diseases, by Region, 2017 - 2029 (USD Million)
7. Infectious Disease
1. Global Artificial Intelligence in Drug Discovery Market, by Infectious Disease, by Region, 2017 - 2029 (USD Million)
8. Others
1. Global Other Artificial Intelligence in Drug Discovery Market, by Region, 2017 - 2029 (USD Million)
7. Global Artificial Intelligence in Drug Discovery Market, by Offering
1. Key Findings
2. Introduction
1. Global Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
3. Software
1. Global Artificial Intelligence in Drug Discovery Market, by Software, By Region, 2017 - 2029 (USD Million)
4. Services
1. Global Artificial Intelligence in Drug Discovery Market, by Services, By Region, 2017 - 2029 (USD Million)
8. Global Artificial Intelligence in Drug Discovery Market, by Technology
1. Key Findings
2. Introduction
1. Global Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Machine Learning
1. Global Artificial Intelligence in Drug Discovery Market, By Machine Learning, By Region, 2017 - 2029 (USD Million)
2. Deep Learning
1. Global Artificial Intelligence in Drug Discovery Market, By Deep Learning, By Region, 2017 - 2029 (USD Million)
3. Supervised Learning
1. Global Artificial Intelligence in Drug Discovery Market, By Supervised Learning, By Region, 2017 - 2029 (USD Million)
4. Reinforcement Learning
1. Global Artificial Intelligence in Drug Discovery Market, By Reinforcement Learning, By Region, 2017 - 2029 (USD Million)
5. Unsupervised Learning
1. Global Artificial Intelligence in Drug Discovery Market, By Unsupervised Learning, By Region, 2017 - 2029 (USD Million)
6. Other Machine Learning Technologies
1. Global Artificial Intelligence in Drug Discovery Market, By Other Machine Learning Technologies, By Region, 2017 - 2029 (USD Million)
4. Other Technologies
1. Global Artificial Intelligence in Drug Discovery Market, by Other Technologies, by Region, 2017 - 2029 (USD Million)
9. Global Artificial Intelligence in Drug Discovery Market, by Geography
1. Key findings
2. Introduction
1. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2017 - 2029 (USD Million)
3. Artificial Intelligence in Drug Discovery Market – North America
1. North America: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. North America: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. North America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. North America: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
5. Artificial Intelligence in Drug Discovery Market – U.S.
1. U.S.: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. U.S.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. U.S.: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. U.S.: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
6. Artificial Intelligence in Drug Discovery Market – Canada
1. Canada: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Canada.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Canada: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Canada: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
4. Artificial Intelligence in Drug Discovery Market – Europe
1. Europe: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Europe.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Europe: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Europe: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
5. Artificial Intelligence in Drug Discovery Market – UK
1. UK: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. UK.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. UK: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. UK: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
6. Artificial Intelligence in Drug Discovery Market – France
1. France: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. France.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. France: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. France: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
7. Artificial Intelligence in Drug Discovery Market – Germany
1. Germany: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Germany.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Germany: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Germany: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
5. Artificial Intelligence in Drug Discovery Market – Asia Pacific
1. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
5. Artificial Intelligence in Drug Discovery Market – China
1. China: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. China: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. China: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. China: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
6. Artificial Intelligence in Drug Discovery Market – Australia
1. Australia: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Australia.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Australia: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Australia: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
7. Artificial Intelligence in Drug Discovery Market – Japan
1. Japan: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Japan: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Japan: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Japan: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
6. Artificial Intelligence in Drug Discovery Market – Latin America
1. Latin America: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Latin America: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Latin America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Latin America: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
7. Artificial Intelligence in Drug Discovery Market – Middle East & Africa
1. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
2. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
3. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
4. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
10. Competitive Landscape
1. Expansion and Acquisition Analysis
1. Expansion
2. Acquisitions
2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
1. Aria Pharmaceuticals, Inc.
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
2. Atomwise
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
3. Benevolent AI
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
4. Berg Health
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
5. BIOAGE
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
6. BioSymetrics
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
7. Cloud Pharmaceuticals
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
8. Cyclica
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
9. Deep Genomics
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
10. DeepMind
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
11. Envisagenics
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
12. Euretos
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
13. Exscientia
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
14. GNS Healthcare
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
15. IBM Corporation
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
16. Insilico Medicine
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
17. Insitro
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
18. NuMedii
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
19. Numerate
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
20. NVIDIA Corporation
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
21. OWKIN, Inc.
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
22. Model Medicines
1. Company Overview
2. Product Benchmarking
3. Recent Development
23. Verge Genomics
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development
24. XtalPi Inc.
1. Company Overview
2. Financial Performance
3. Product Benchmarking
4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings